Osteonecrosis of the Jaw in a Patient Presenting With Post-Transplantation Lymphoproliferative Disorder Treated With Rituximab: A Case Report

被引:14
|
作者
Keribin, Pierre [1 ]
Guerrot, Dominique [2 ,3 ]
Jardin, Fabrice [4 ,5 ]
Moizan, Herve [1 ]
机构
[1] Rouen Univ Hosp, Dept Oral Surg & Odontol, Rouen, France
[2] Normandie Univ, INSERM, U1096, UNIROUEN, Rouen, France
[3] Univ Rouen, Dept Nephrol, Rouen, France
[4] Normandie Univ, INSERM, U918, UNIROUEN, Rouen, France
[5] Henri Becquerel Canc Ctr, Dept Clin Hematol, Rouen, France
关键词
MONOCLONAL-ANTIBODY; ASSOCIATION; BISPHOSPHONATE; LEUKEMIA;
D O I
10.1016/j.joms.2017.05.016
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Osteonecrosis of the jaw (ONJ) is a rare but potentially severe condition that can be induced by specific treatments. We report the case of a 69-year-old male kidney transplant recipient who presented with ONJ 5 years after transplantation. The patient presented with ulcerations of the oral mucosa related to post-transplantation lymphoproliferative disorder, which was treated with rituximab. Subsequently, ONJ developed. Although rituximab treatment cannot be firmly established as the cause of this condition, similar cases of ONJ have been reported after treatment with this monoclonal antibody. This case raises a potential link between rituximab treatment and ONJ and prompts further studies to investigate the potential impact of rituximab on bone angiogenesis. (C) 2017 American Association of Oral and Maxillofacial Surgeons
引用
收藏
页码:2599 / 2605
页数:7
相关论文
共 50 条
  • [2] Post-transplantation lymphoproliferative disorder
    Schooler, VC
    Ragland, B
    Lazenby, A
    Eloubeidi, MA
    GASTROINTESTINAL ENDOSCOPY, 2004, 60 (06) : 989 - 990
  • [3] Post-transplant lymphoproliferative disorder treated with rituximab: case report
    Meng Hai-tao
    Li Ying
    Liu Jian-hua
    Xu Gai-xiang
    Teng Xiao-dong
    CHINESE MEDICAL JOURNAL, 2007, 120 (09) : 841 - 843
  • [4] Post-transplant lymphoproliferative disorder treated with rituximab:case report
    MENG Hai-tao LI Ying LIU Jian-hua XU Gai-xiang TENG Xiao-dong Department of Hematology (Meng HT Li Y Xu GX)Department of Stomatology (Liu JH)Department of Pathology (Teng XD)First Affiliated Hospital of Zhejiang University
    中华医学杂志(英文版), 2007, (09) : 841 - 843
  • [5] Post-transplant lymphoproliferative disorder treated with rituximab:case report
    MENG Haitao LI Ying LIU Jianhua XU Gaixiang TENG Xiaodong Department of Hematology Meng HT Li Y Xu GXDepartment of Stomatology Liu JHDepartment of Pathology Teng XDFirst Affiliated Hospital of Zhejiang University Hangzhou China
    Chinese Medical Journal, 2007, 120 (09) : 841 - 843
  • [6] Rituximab, Cyclophosphamide, Etoposide and Prednisone for the Treatment of Post-Transplantation Lymphoproliferative Disorder
    Muenzen, Reid M.
    Hughes, Mitchell E.
    Nasta, Sunita Dwivedy
    Svoboda, Jakub
    Landsburg, Daniel J.
    Barta, Stefan K.
    Tsai, Donald
    Schuster, Stephen J.
    Chong, Elise A.
    BLOOD, 2022, 140 : 6715 - 6716
  • [9] Terminal Ileac Ulcers Mimicked Post-transplantation Lymphoproliferative Disorder in a Heart Recipient Treated With Everolimus: A Case Report
    Iwasaki, K.
    Seguchi, O.
    Mochizuki, H.
    Kimura, Y.
    Toda, K.
    Kumai, Y.
    Kuroda, K.
    Nakajima, S.
    Watanabe, T.
    Yanase, M.
    Matsumoto, Y.
    Fukushima, S.
    Fujita, T.
    Kobayashi, J.
    Fukushima, N.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (10) : 4053 - 4056
  • [10] Unusual gingival presentation of post-transplantation lymphoproliferative disorder: A case report and review of the literature
    Raut, A
    Huryn, J
    Pollack, A
    Zlotolow, I
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2000, 90 (04): : 436 - 441